Ibnsina Pharma (ISPH.CA) Reports Its Financial Results (Standalone) for The Period From 01/01/2026 to 31/03/2026

Company Name: Ibnsina Pharma
ISIN Code: EGS512O1C012
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 31/03/2026
Net profit: 246,274,405
F/S (Standalone) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 176,331,444
Audit Status: Reviewed
Source: Ibnsina Pharma